Page last updated: 2024-10-25

clenbuterol and Neuronal Ceroid-Lipofuscinoses

clenbuterol has been researched along with Neuronal Ceroid-Lipofuscinoses in 1 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.

Research Excerpts

ExcerptRelevanceReference
"Treatment with clenbuterol, a beta(2)-adrenoceptor agonist that can enhance regeneration of motor neuron axons, opposed the development of motor deficits in parallel with a reduced proportion of motor neurons with eccentric nuclei consistent with improved synaptic function."1.32Clenbuterol retards loss of motor function in motor neuron degeneration mice. ( Etlinger, JD; Peng, H; Zeman, RJ, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zeman, RJ1
Peng, H1
Etlinger, JD1

Other Studies

1 other study available for clenbuterol and Neuronal Ceroid-Lipofuscinoses

ArticleYear
Clenbuterol retards loss of motor function in motor neuron degeneration mice.
    Experimental neurology, 2004, Volume: 187, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Diagnostic Techniques, Neurological; Disease Models,

2004